Research & expertise
Our people
News & resources
About us
Support us

DONATE

Home > News & resources > Scope newsletters > Scope 84 | Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy

Scope 84 | Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy

News
Scope newsletters
Immunology & immunotherapy

Intro text here

Keep up with the pace of our research

First name

Last name

Email*

reCaptcha is required*

Thank you for subscribing to our mailing list. Keep an eye on your inbox for the latest updates on our medical research and discoveries.

Privacy and security
Social media community guidelines

Copyright © 2024 Malaghan Institute of Medical Research.

Contact Us

Email: [email protected]

Phone: +64 4 499 6914

Charity Reg. Number: CC 10357

Follow Us